SCHEMBL16291896

SCHEMBL16291896

CCCCCNC(=O)CNCc1cc(C(=O)O)ccn1

nearest known ligand 0.57

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ KDM5B Q9UGL1 14/20 0.57
▸ KDM5A P29375 9/20 0.57
▸ KDM5C P41229 7/20 0.57
▸ KDM4A O75164 3/20 0.57
▸ KDM6B O15054 1/20 0.55
▸ KDM2B Q8NHM5 1/20 0.55
▸ NAAA Q02083 1/20 0.44
▸ KDM4C Q9H3R0 3/20 0.44
▸ KDM5D Q9BY66 1/20 0.43
▸ XDH P47989 1/20 0.42
▸ KDM4B O94953 1/20 0.42
▸ HCAR3 P49019 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16291759 0.86 KDM5B (0.49) KDM5BKDM5AKDM5CKDM4AKDM6B
SCHEMBL18708529 0.79 KDM5B (0.55) KDM5BKDM5AKDM5CKDM4AKDM6B
SCHEMBL16291866 0.78 KDM5B (0.44) KDM5BKDM5AKDM5CKDM4AKDM6B
SCHEMBL15636266 0.78 KDM5B (0.74) KDM5BKDM5AKDM5CKDM4AKDM6B
SCHEMBL18160870 0.76 POLB (0.53) —
SCHEMBL19676453 0.76 KDM5B (0.65) KDM5BKDM5AKDM5CKDM4AKDM6B
SCHEMBL16291869 0.76 KDM5B (0.50) KDM5BKDM5AKDM5CKDM4AKDM6B
SCHEMBL28092824 0.75 KDM5A (0.58) KDM5BKDM5AKDM5CKDM4AKDM6B
SCHEMBL15637200 0.75 KDM5B (0.58) KDM5BKDM5AKDM5CKDM4AKDM6B
SCHEMBL16291684 0.74 KDM5B (0.64) KDM5BKDM5AKDM5CKDM4AKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10189787-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2019-01-29 — — US disclosed
US-9611219-B2 — — 2017-04-04 — — US disclosed
US-9611220-B2 — — 2017-04-04 — — US disclosed
US-20150203453-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2015-07-23 — — US disclosed
US-20140371195-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2014-12-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189787-B2 Inhibitors of histone demethylases EHMT1, KDM1B, EHMT2 KDM5B 34/4885KDM5A 24/4885KDM5C 31/4885
US-20150203453-A1 INHIBITORS OF HISTONE DEMETHYLASES EHMT1, KDM1B, EHMT2 KDM5B 34/4885KDM5A 25/4885KDM5C 31/4885
US-20140371195-A1 INHIBITORS OF HISTONE DEMETHYLASES EHMT1, KDM1B, EHMT2 KDM5B 34/4885KDM5A 24/4885KDM5C 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback